# Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine

> **NCT05211050** · NA · COMPLETED · sponsor: **Danish Headache Center** · enrollment: 24 (actual)

## Conditions studied

- Migraine Without Aura
- Headache

## Interventions

- **DRUG:** Levcromakalim
- **DRUG:** Sumatriptan
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05211050
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2023-11-05
- **Final completion:** 2023-11-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05211050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05211050, "Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05211050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*